decisionhealth Newsletters, Part B News - 2000 Issue 12 (December)
Average wholesale drug prices to remain, no cuts in near future, HCFA says
Subscribe or sign in to view the full article.
Article Overview
This article covers a Medicare payment policy update involving average wholesale drug prices and a proposed shift in the data source used by HCFA for reimbursement calculations. It discusses why the agency delayed implementation, how pending legislation could affect the timing, and why the issue matters to physicians, carriers, and other stakeholders following Medicare drug payment policy.
Why This Topic Matters
The article is relevant to practices that bill Medicare for injectable or other covered drugs because it signals possible changes in reimbursement timing and policy direction. It also places the update in the context of congressional action, agency guidance, and federal oversight of drug pricing.
What You Will Learn
- How HCFA’s planned drug reimbursement change was delayed
- What pending legislation could mean for the timing of policy implementation
- Why federal agencies and lawmakers were involved in the pricing issue
- How the topic affects Medicare drug payment policy at a high level
Who Should Read This
- Physicians
- Medical practice billing staff
- Revenue cycle staff
- Coding professionals
- Healthcare administrators
- Medicare reimbursement stakeholders
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com